Press release
Deadline in Lawsuit coming up on July 27th for Investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
A Deadline is coming up on July 27, 2020 in the lawsuit for certain investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE).
Investors who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) have certain options and there are strict and short deadlines running. Deadline: July 27, 2020. NASDAQ: SRNE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges on behalf of purchasers of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) common shares between May 15, 2020 and May 22, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 15, 2020 and May 22, 2020, Sorrento Therapeutics, Inc. failed to disclose that the Company’s initial finding of “100% inhibition” in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person, that the Company’s finding was not a “cure” for COVID-19; and (ii) as a result of the foregoing, the lawsuit alleges that Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis in violation of section 10(b) of the Securities Exchange Act of 1934.
Those who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline in Lawsuit coming up on July 27th for Investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE) here
News-ID: 2090780 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Sorrento
T-Cell Therapy Market global outlook and forecast 2021 -2027|Sorrento Therapeuti …
The Global T-Cell Therapy Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a T-Cell Therapy makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements.
The report likewise spins around…
CAR T-Cell Therapy Market 2020-2026 Precise Outlook-Pfizer, CARsgen Therapeutics …
This report studies the CAR T-Cell Therapy Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete CAR T-Cell Therapy Market analysis segmented by companies, region, type, and applications in the report.
The report offers valuable insight into the CAR T-Cell Therapy market…
Investigation announced for Long-Term Investors in shares of Sorrento Therapeuti …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Sorrento Therapeutics, Inc..
Investors who are current long term investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SRNE stocks follows a lawsuit filed against Sorrento…
Lawsuit filed for Investors in shares of Sorrento Therapeutics, Inc. (NASDAQ: SR …
The Shareholders Foundation announced that an investor, who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), filed a lawsuit over alleged Securities Laws violations by Sorrento Therapeutics, Inc.
Investors who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) have certain options and for certain investors are short and strict deadlines running. Deadline: July 27, 2020. NASDAQ: SRNE investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San…
Natural Killer Cells Market Insights With Key Players NantKwest, NKT Therapeutic …
Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent…
K Cells Market Size, Status and Forecast to 2025| Takeda Pharmaceutical| Sorrent …
HTF MI released a new market study on Global K Cells Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates…
